Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processing

European Journal of Immunology

Volumn 45, Issue 3, 2015, Pages 716-727

  Fiebiger, Benjamin M ^a,b,c   Pfister, Heike ^a,b   Behrends, Uta ^a,b,c   Mautner, Josef ^a,b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Institute of Radiation Medicine   (Germany)

^c German Centre for Infection Research (DZIF)   (Germany)

Author keywords

Antigen presentation; Antigen processing; MHC class I; Proteasome; Ubiquitin

Indexed keywords

DEUBIQUITINASE; IMMEDIATE EARLY PROTEIN BZLF1; LYSINE; LYSINE 48; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG; ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; EXPRESSION VECTOR; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGENICITY; POLYUBIQUITINATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; AMINO ACID SUBSTITUTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; IMMUNOLOGY; MISSENSE MUTATION; PHYSIOLOGY; UBIQUITINATION;

AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; ANTIGENS; HEK293 CELLS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYSINE; MUTATION, MISSENSE; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITINATION;

EID: 84924632659     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444830     Document Type: Article

References (42)

1. Sijts, E. J. and Kloetzel, P. M., The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 2011. 68: 1491-1502.
2. Rock, K. L. and Goldberg, A. L., Degradation of cell proteins and the generation of MHC class I-presented peptides. Ann. Rev. Immunol. 1999. 17: 739-779.
3. Blum, J. S., Wearsch, P. A. and Cresswell, P., Pathways of antigen processing. Ann. Review Immunol. 2013. 31: 443-473.
4. van Endert, P., Post-proteasomal and proteasome-independent generation of MHC class I ligands. Cell. Mol. Life Sci. 2011. 68:1553-1567.
5. Yewdell, J. W., DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol. 2011. 32: 548-558.
6. Ciechanover, A. and Ben-Saadon, R., N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 2004. 14: 103-106.
7. Cadwell, K. and Coscoy, L., Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005. 309: 127-130.
8. Ravid, T. and Hochstrasser, M., Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nat. Cell Biol. 2007. 9: 422-427.
9. Wang, X., Herr, R. A., Chua, W. J., Lybarger, L., Wiertz, E. J. and Hansen, T. H., Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 2007. 177: 613-624.
10. Shimizu, Y., Okuda-Shimizu, Y. and Hendershot, L. M., Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids. Mol. Cell. 2010. 40: 917-926.
11. Husnjak, K. and Dikic, I., Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Ann. Rev. Biochem. 2012. 81: 291-322.
12. Ciechanover, A. and Stanhill, A., The Complexity of Recognition of Ubiquitinated Substrates by the 26S Proteasome. Biochim. et Biophys. Acta 2014.1843: 86-96.
13. Metzger, M. B., Hristova, V. A. and Weissman, A. M., HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 2012. 125: 531-537.
14. Nagy, V. and Dikic, I., Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity. Biol. Chem. 2010. 391: 163-169.
15. Jariel-Encontre, I., Bossis, G. and Piechaczyk, M., Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta. 2008. 1786: 153-177.
16. Cox, J. H., Galardy, P., Bennink, J. R. and Yewdell, J. W., Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 1995. 154: 511-519.
17. Michalek, M. T., Grant, E. P., Gramm, C., Goldberg, A. L. and Rock, K. L., A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993. 363: 552-554.
18. Huang, L., Marvin, J. M., Tatsis, N. and Eisenlohr, L. C., Cutting edge: selective role of ubiquitin in MHC class I antigen presentation. J. Immunol. 2011. 186:1904-1908.
19. Dolan, B. P., Li, L., Veltri, C. A., Ireland, C. M., Bennink, J. R. and Yewdell, J. W., Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J. Immunol. 2011. 186:2065-2072.
20. Qian, S. B., Princiotta, M. F., Bennink, J. R. and Yewdell, J. W., Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J. Biol. Chem. 2006. 281: 392-400.
21. Fruci, D., Lauvau, G., Saveanu, L., Amicosante, M., Butler, R. H., Polack, A., Ginhoux, F. et al., Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport. J. Immunol. 2003. 170:2977-2984.
22. Princiotta, M. F., Finzi, D., Qian, S. B., Gibbs, J., Schuchmann, S., Buttgereit, F., Bennink, J. R. et al., Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003. 18: 343-354.
23. D'Arcy, P., Brnjic, S., Olofsson, M. H., Fryknas, M., Lindsten, K., De Cesare, M., Perego, P. et al., Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med. 2011. 17:1636-1640.
24. Finley, D., Recognition and processing of ubiquitin-protein conjugates by the proteasome. Ann. Rev. Biochem. 2009. 78: 477-513.
25. Dolan, B. P., Bennink, J. R. and Yewdell, J. W., Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell. Mol. Life Sci. 2011. 68:1481-1489.
26. McDowell, G. S. and Philpott, A., Non-canonical ubiquitylation: mechanisms and consequences. Int. J. Biochem. Cell Biol. 2013. 45:1833-1842.
27. Yewdell, J. W., Reits, E. and Neefjes, J., Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 2003. 3: 952-961.
28. Stack, J. H., Whitney, M., Rodems, S. M. and Pollok, B. A., A ubiquitin-based tagging system for controlled modulation of protein stability. Nat. Biotechnol. 2000. 18: 1298-1302.
29. Setz, C., Friedrich, M., Hahn, S., Dorrie, J., Schaft, N., Schuler, G. and Schubert, U., Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitin. PLos One 2013. 8: e55567.
30. Andersson, H. A. and Barry, M. A., Maximizing antigen targeting to the proteasome for gene-based vaccines. Mol. Ther. 2004. 10: 432-446.
31. Varshavsky, A., The N-end rule pathway and regulation by proteolysis. Protein Sci. 2011. 20: 1298-1345.
32. Orlowski, M. and Wilk, S., Ubiquitin-independent proteolytic functions of the proteasome. Arch. Biochem. Biophys. 2003. 415: 1-5.
33. Huang, L., Kuhls, M. C. and Eisenlohr, L. C., Hydrophobicity as a driver of MHC class I antigen processing. EMBO J. 2011. 30: 1634-1644.
34. Kunisawa, J. and Shastri, N., Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006. 24: 523-534.
35. Callahan, M. K., Garg, M. and Srivastava, P. K., Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation. Proc. Natl. Acad. Sci. USA 2008. 105: 1662-1667.
36. Xu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., Rush, J. et al., Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009. 137: 133-145.
37. Kriegenburg, F., Ellgaard, L. and Hartmann-Petersen, R., Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J. 2012. 279: 532-542.
38. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M. et al., Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 1995. 154: 2257-2265.
39. Fiebiger, B. M., Moosmann, A., Behrends, U. and Mautner, J., Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool. Eur. J. Immunol. 2012. 42: 3167-3173.
40. Nimmerjahn, F., Milosevic, S., Behrends, U., Jaffee, E. M., Pardoll, D. M., Bornkamm, G. W. and Mautner, J., Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 2003. 33: 1250-1259.
41. Holzel, M., Rohrmoser, M., Orban, M., Homig, C., Harasim, T., Malamoussi, A., Gruber-Eber, A. et al., Rapid conditional knock-down-knock-in system for mammalian cells. Nucleic Acids Res. 2007. 35: e17.
42. Johnson, E. S., Bartel, B., Seufert, W. and Varshavsky, A., Ubiquitin as a degradation signal. Embo. J. 1992. 11: 497-505.